Search / Trial NCT06616337

Patients Suffering From Emotional Dysregulation

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Sep 23, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Emotional Dysregulation Schizophrenia Bipolar Disorder Borderline Personality Disorder Attention Deficit Hyperactivity Disorder (Adhd)

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Major subject (≥18 years old)
  • * Having participated in the first session of a GREMO group, which is a behavioral and dialectical therapy protocol from January 1, 2018 to December 31, 2023,
  • * Subject not opposing the reuse of their data for scientific research purposes.
  • Exclusion Criteria:
  • * Subject having expressed their opposition to the reuse of their personal data for scientific research purposes.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Strasbourg, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0